Latest News and Press Releases

SOUTH SAN FRANCISCO, Calif., May 22, 2026 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (Nasdaq: ASMB), a biotechnology company developing innovative therapeutics targeting serious viral and liver...

– Phase 2 study in cholestatic liver diseases, focused on PBC and PSC, anticipated to initiate in Q1 2027 –– Builds on completed Phase 1a study and ongoing development in HDV – SOUTH SAN FRANCISCO,...

NEW YORK, May 21, 2026 (GLOBE NEWSWIRE) -- Market News Updates News Commentary - The market for peptide-based health and performance products has been growing fast as more consumers focus on...

Oncology focused biotech to utilise 4basebio’s opDNA® technology to support Phase II clinical trial of immunotherapy candidate Multi-year, seven-figure revenue stream reflecting increased commercial...

CAMBRIDGE, UK – 20 May 2026 – 4basebio plc (AIM: 4BB), a company pioneering an enzymatically-produced DNA technology serving the next generation genetic medicines markets, announces its audited final...

– Alterity’s novel imaging and biomarker approach positions the Company at the forefront of clinical research in MSA –  – End-of-Phase 2 FDA Meeting on track for mid-2026 to confirm path forward for...

Meet Avance Clinical's Oncology Center of Excellence expert team at ASCO Annual Meeting in Chicago, held 29 May – 2 June 2026.

Covering five recent reports, the review examines how advances in biotechnology are supporting protein production, therapeutic innovation and life sciences

Novastra Therapeutics appoints Jarett Poll as CFO as the clinical-stage immuno-oncology company advances OAP-101 toward global clinical development.

Alaunos reports preclinical ALN1003 data showing effects on insulin resistance biomarkers and liver histology in obesity mouse models.